science/health

AI News

AI Draws $1.4 Billion in Strategic Investments for Cardiovascular Drug Development

Investment in artificial intelligence for cardiovascular drug development has surpassed $1.4 billion, according to recent industry reporting. The substantial capital deployment reflects increasing pharmaceutical industry conviction that AI and machine learning tools can meaningfully compress timelines and reduce costs in bringing new cardiovascular treatments to market. Cardiovascular disease remains
Alper Konuralp